Neuroscience

Scientists capture first image of major brain receptor in action

Columbia University Medical Center (CUMC) researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, ...

Alzheimer's disease & dementia

New drug reverses loss of brain connections in Alzheimer's disease

The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines ...

Psychology & Psychiatry

Scientists explain how ketamine vanquishes depression within hours

(Medical Xpress)—Many chronically depressed and treatment-resistant patients experience immediate relief from symptoms after taking small amounts of the drug ketamine. For a decade, scientists have been trying to explain ...

Genetics

Many migraines may have a common genetic basis

(Medical Xpress) -- A study into the genetic basis of many common forms of migraine has identified three variants that suggest that most forms of migraine have a shared genetic foundation, regardless of how they manifest ...

Psychology & Psychiatry

Bullied teens' brains show chemical change associated with psychosis

Researchers have found that adolescents being bullied by their peers are at greater risk of the early stages of psychotic episodes and in turn experience lower levels of a key neurotransmitter in a part of the brain involved ...

Neuroscience

The discovery of a new kind of cell shakes up neuroscience

A research team from University of Lausanne (UNIL) and the Wyss Center, has discovered a new type of cell essential for brain function. Hybrid in composition and function, in between the two types of brain cells known so ...

page 1 from 22